Core D: Research Support Core
核心 D:研究支持核心
基本信息
- 批准号:10559682
- 负责人:
- 金额:$ 11.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-28 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AnimalsAntibodiesAromatic HydrocarbonsAromatic Polycyclic HydrocarbonsAwardBiological AssayBronchopulmonary DysplasiaCancer Center Support GrantChIP-seqChromatinChronic lung diseaseClinicalCommunitiesComputers and Advanced InstrumentationConsultationsCore FacilityDNA MethylationDataData AnalysesData SetDetectionDevelopmentDoseEducational workshopEnsureEnzymesEpigenetic ProcessExperimental DesignsExperimental ModelsExposure toFacultyFundingGeneticGenomicsGoalsGrantHumanIndividualInfrastructureInstitutionMass FragmentographyMass Spectrum AnalysisMeasuresMentorsMetabolicMethodsMolecularMolecular ProfilingNeurocognitive DeficitOutcomeOxidation-ReductionPhasePostdoctoral FellowPregnant WomenPremature BirthPreventionProceduresProgress ReportsProtein ArrayProteomicsProtocols documentationResearchResearch InstituteResearch PersonnelResearch Project SummariesResearch SupportResourcesRiceServicesSignal Recognition ParticleSiteSuperfundTechniquesTechnologyTrainingValidationWorkanalytical methodanticancer researchbiomarker identificationbiomarker signaturebisulfite sequencingcancer preventiondata managementdesigndoctoral studentearly life exposureepigenetic profilingepigenomicsexperiencegenome sequencinggenome-widegenomic platformgraduate studenthigh riskhistone modificationinvestigator trainingmetabolomicsmultiple omicsneurobehavioralnovelorganizational structurepostnatalprenatalpreterm newbornremediationskillssuperfund sitesupplemental oxygentechnology platformtraining opportunitytranscriptome sequencingtranscriptomicswhole genome
项目摘要
Project Summary
The Research Support Core (RSC) will provide a wide range of high quality quantitative analytical technology
platforms spanning metabolomics, epigenomics, transcriptomics, and proteomics. The RSC leader is Dr. Dean
P. Edwards, Executive Director of the Advanced Technology Cores at BCM. The RSC co-leader is Dr. Nagireddy
Putluri, who also serves as director of the Metabolomics Core and is a recognized leader in mass spectrometry-
based metabolomics profiling. The RSC has the following specific aims. AIM 1 Will effectively support the
Superfund projects with cutting edge quantitative multi-omics technologies. Established Core technologies
available includes mass spectrometry-based targeted and unbiased metabolomics, unbiased proteomic profiling
by mass spectrometry, targeted proteomics by antibody-based reverse phase protein array (RPPA) and
genomics platforms such as whole genome sequencing, transcriptomics by RNA-seq, smallRNA sequencing
and epigenetics by ChIP-Seq. RSC support will include intellectual input from faculty level Core Directors for
consultation and experimental design, hosting of advanced instrumentation, executing state-of-the-art analytical
procedures by research staff of Cores and processing and analysis of “omics” data sets. RSC technology
platforms will be used primarily in Projects 2, 3 and 4 to identify biomarkers and molecular signatures of polycyclic
aromatic hydrocarbon (PAH) exposures associated with preterm birth (PTB) and to define the molecular
mechanisms underlying the potentiating effects of PAH and its derivatives on chronic lung
disease/bronchopulmonary dysplasia (BPD) and neurobehavioral deficits in experimental models and in human
studies. The metabolomics core will additionally be instrumental for measuring and quantification of PAH and its
metabolites by GC-MS as a standard for development of more sensitive and less sophisticated assays in Projects
1 and 2. AIM 2 Will continuously work with Project leaders and investigators to develop, validate, and deploy
novel methods during the course of the grant that are not currently standard Core procedures. This will initially
include MS identification of novel PAH derivatives and metabolites, and unbiased metabolomics profiling,
epigenetic profiling of histone modifications and chromatin modifying enzymes by RPPA, genome-wide DNA
methylation by bisulfite sequencing and Redox proteomics by MS methods. AIM 3 Will train investigators in
designing, executing, and interpreting results of the state-of-the-art analytical techniques conducted by the RSC.
This will be accomplished by providing tutorials, workshops and some hands-on opportunities for principle
investigators of the Superfund grant and their post-doctoral and graduate student trainees. The ultimate goal
of the RSC is to provide cutting-edge technical and the best quality scientific solutions available for the Superfund
investigators for use in their Aims of understanding PAH exposures at molecular mechanistic and genetic levels.
项目摘要
研究支持核心(RSC)将提供广泛的高质量定量分析技术
平台涵盖代谢组学、表观基因组学、转录组学和蛋白质组学。RSC的领导人是迪恩博士
P.爱德华兹,先进技术核心的执行董事在英特尔。RSC的共同领导人是Nagireddy博士
Putluri也是代谢组学核心的主任,是质谱分析领域公认的领导者,
基于代谢组学分析。区域服务中心有以下具体目标。AIM 1将有效支持
超级基金项目与尖端的定量多组学技术。核心技术
包括基于质谱的靶向和无偏代谢组学、无偏蛋白质组学分析
通过质谱,通过基于抗体的反相蛋白质阵列(RPPA)的靶向蛋白质组学,
基因组学平台,如全基因组测序、RNA-seq转录组学、小RNA测序
和ChIP-Seq的表观遗传学RSC支持将包括来自教师级核心主任的智力投入,
咨询和实验设计,托管先进仪器,执行最先进的分析
核心研究人员的程序以及“组学”数据集的处理和分析。RSC技术
平台将主要用于项目2、3和4,以确定多环芳烃的生物标志物和分子特征。
与早产(PTB)相关的芳烃(PAH)暴露,并定义分子
PAH及其衍生物增强慢性肺损伤作用的机制
疾病/支气管肺发育不良(BPD)和神经行为缺陷的实验模型和人类
问题研究代谢组学核心还将有助于测量和定量PAH及其
通过GC-MS分析代谢物,作为开发更灵敏和更简单分析的标准。
1和2. AIM 2将继续与项目领导和研究人员合作,开发、验证和部署
在赠款过程中采用新的方法,而目前不是标准的核心程序。这将首先
包括新型PAH衍生物和代谢物MS鉴定,以及无偏代谢组学分析,
通过RPPA、全基因组DNA对组蛋白修饰和染色质修饰酶进行表观遗传分析
甲基化和氧化还原蛋白质组学。AIM 3将培训调查人员,
设计、执行和解释RSC进行的最先进分析技术的结果。
这将通过提供教程,研讨会和一些动手的机会,原则
研究生和博士后研究生的培训。最终目标
RSC的使命是为超级基金提供最先进的技术和最优质的科学解决方案
研究人员用于在分子机制和遗传水平上了解多环芳烃暴露的目的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean P Edwards其他文献
Dean P Edwards的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean P Edwards', 18)}}的其他基金
Structural dynamics of progesterone receptor-coactivator complexes
黄体酮受体-辅激活剂复合物的结构动力学
- 批准号:
10626857 - 财政年份:2022
- 资助金额:
$ 11.76万 - 项目类别:
Structural dynamics of progesterone receptor-coactivator complexes
黄体酮受体-辅激活剂复合物的结构动力学
- 批准号:
10446155 - 财政年份:2022
- 资助金额:
$ 11.76万 - 项目类别:
INHIBITION OF SECRETORY ACTIVATION BY PROGESTERON
黄体酮对分泌激活的抑制
- 批准号:
7634423 - 财政年份:2008
- 资助金额:
$ 11.76万 - 项目类别:
DIRECT AND INDIRECT MECHANISM FOR THE INHIBITION OF SECRETORY ACTIVATION BY PROGE
PROGE 抑制分泌激活的直接和间接机制
- 批准号:
7018037 - 财政年份:2005
- 资助金额:
$ 11.76万 - 项目类别:
Progesterone Inhibition--Milk Protein Gene Transcription
黄体酮抑制--乳蛋白基因转录
- 批准号:
6602427 - 财政年份:2002
- 资助金额:
$ 11.76万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 11.76万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 11.76万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 11.76万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 11.76万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 11.76万 - 项目类别: